Aion Therapeutic Inc.
ANTCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$994.3K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $994,299.00 |
|---|---|
| Enterprise Value | $4.01 Million |
| Earnings per Share | $-0.02 |
| Beta | 4.71 |
| Outstanding Shares | 497,149,269 |
Return
| Return on Equity | 142.22% |
|---|---|
| Return on Assets | -550.85% |
| Return on Invested Capital | 135.13% |
Valuation & Multiples
| P/E Ratio | -0.21 |
|---|---|
| PEG | 0.93 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 2.72 |
| Enterprise Value to EBIT | -0.63 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | -0.65 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aion Therapeutic Inc.
5 employees
CEO: John Graham Simmonds Jr.
Aion Therapeutic Inc. operates within Canada, focusing on the provision of medicinal cannabis products. The company, which commenced operations in 2011, adopted its current name, Aion Therapeutic Inc., in August 2020, having previously b...